Godavari Drugs Limited

530317

INE362C01012

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:54 2024-05-02 am EDT			5-day change	1st Jan Change
100.5 ^INR	-0.41%		+0.94%	+11.59%

Feb. 13	Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
Feb. 13	Godavari Drugs Limited Appoints Dinesh Udpa as Non-Executive-Independent Director	CI

Godavari Drugs Limited Appoints Mahendra Uday Bhalerao as Non-Executive Independent Director

December 28, 2022 at 02:42 am EST

Godavari Drugs Limited announced that M. Mahendra Uday Bhalerao is appointed as Non-executive Independent Director of the Company & Mr. Ghanshyam Jaju is reappointed as Non-executive Non-Independent Director of the Company effective from December 27, 2022.

Latest news about Godavari Drugs Limited

Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 13	CI
Godavari Drugs Limited Appoints Dinesh Udpa as Non-Executive-Independent Director	Feb. 13	CI
Godavari Drugs' Profit Flat in Fiscal Q2	Nov. 15	MT
Godavari Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14	CI
Godavari Drugs Limited Announces Resignation of Ramesh Babu Telugu from the Post of Independent Director	23-08-11	CI
Godavari Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Godavari Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-07-21	CI
Godavari Drugs Limited Approves the Appointment of Mr. Venkatesh Achanta as Company Secretary	23-05-29	CI
Godavari Drugs Limited Announces Executive Changes	23-03-15	CI
Godavari Drugs Limited Announces Resignation of Mrs. Rashmi Agarwal as Company Secretary and Compliance Officer	23-02-14	CI
Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Godavari Drugs Limited Appoints Mahendra Uday Bhalerao as Non-Executive Independent Director	22-12-28	CI
Godavari Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-12	CI
Godavari Drugs Limited Announces Resignation of Mr. Dilip Keshavlal Patel from Post of Non-Executive Independent Director	22-11-12	CI
Godavari Drugs Limited Approves the Appointment of Mahindra Uday Bhalerao as Additional Independent Director	22-11-12	CI
Godavari Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-13	CI
Godavari Drugs' CFO Resigns	22-04-20	MT
Godavari Drugs Limited Announces Resignation of Kirti Kumar Jain from the CFO	22-04-20	CI
Godavari Drugs Limited Announces the Resignation of Kirti Kumar Jain from the Office of Whole-Time Director	22-04-20	CI
Godavari Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-04-19	CI
Godavari Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-04-19	CI
Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-14	CI
Godavari Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-12	CI
Godavari Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-08-14	CI
Godavari Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-06-16	CI

Chart Godavari Drugs Limited

Duration

Period

More charts

Company Profile

Godavari Drugs Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and its intermediates. The Company is engaged in the business of contract manufacturing, loan license manufacturing, manufacturing and supply of API, drug intermediaries and fine chemicals. The Company operates through manufacture and sale of API and its intermediates segment. The Company's manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The facility has multiple production blocks for APIâs, drug intermediates and fine chemicals.

Sector

Pharmaceuticals

Calendar

2024-05-28 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
GODAVARI DRUGS LIMITED	+11.59%	9.1M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.61%	43.18B
OTSUKA HOLDINGS CO., LTD.	+20.67%	22.59B
SANDOZ GROUP AG	+14.56%	14.56B
CIPLA LIMITED	+13.94%	13.54B
ZYDUS LIFESCIENCES LIMITED	+43.35%	11.5B
ONO PHARMACEUTICAL CO., LTD.	-8.37%	6.93B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.36B